Status:
UNKNOWN
Impact of the Coordinated Intervention of the Healthcare Facilities Pharmacist and the Dispensary Pharmacist on the Care Pathway for Cancer Patients Treated With Oral Therapy
Lead Sponsor:
Institut Cancerologie de l'Ouest
Conditions:
Advanced or Metastatic Solid Tumor
Relapsed Hematologic Malignancy
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The rise of oral therapies in the management of cancers has considerably changed the patient care path. If the oral route is preferred by patients because it offers a better quality of life, it is not...
Eligibility Criteria
Inclusion
- Patient aged 18 years old or more
- Having given his written consent to participate in the study
- Patients with advanced or metastatic solid tumor or relapsed hematologic malignancy
- With an initiation of oral therapy
- Performance Status 0, 1 or 2
Exclusion
- Patient receiving ongoing intravenous (IV) or subcutaneous (SC) anticancer treatment
- Patient receiving ongoing oral therapy
- Patient receiving first-generation hormone therapy
- Patient receiving ongoing a coordinated pharmaceutical path
- Patient participating in a therapeutic education program including a pharmacist
- Patient already included in an interventional clinical trial
- Oral therapy with Temporary Authorisation
- Patient in a health or medico-social institution
- Patient protected, under guardianship or unable to give free and informed consent
- Patient does not speak French
- Patient unable to read French
- Patient unable to undergo the medical monitoring of the trial for geographical, social or psychological reasons.
- Patients 70 years old with cognitive disorders identified by the G-CODE
Key Trial Info
Start Date :
April 7 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2024
Estimated Enrollment :
396 Patients enrolled
Trial Details
Trial ID
NCT04327583
Start Date
April 7 2021
End Date
October 1 2024
Last Update
April 28 2022
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut de Cancérologie de l'Ouest
Angers, France, 49055
2
CHU
Angers, France, 49933
3
Ch Cholet
Cholet, France, 49300
4
CHD Vendée
La Roche-sur-Yon, France, 85925